Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA078524-02
Application #
6150043
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (01))
Program Officer
Ault, Grace S
Project Start
1999-04-15
Project End
2004-01-31
Budget Start
2000-02-10
Budget End
2001-01-31
Support Year
2
Fiscal Year
2000
Total Cost
$267,418
Indirect Cost
Name
University of Cincinnati
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Mani, Timmy; Hennigan, Robert F; Foster, Lauren A et al. (2011) FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function. Mol Cell Biol 31:1983-96
Hennigan, Robert F; Foster, Lauren A; Chaiken, Mary F et al. (2010) Fluorescence resonance energy transfer analysis of merlin conformational changes. Mol Cell Biol 30:54-67
Hennigan, Robert F; Chaiken, Mary F; Foster, Lauren A et al. (2009) A FRET-based approach for studying conformational changes of a cytoskeleton-related tumor suppressor molecule. Methods Mol Biol 586:143-56
Lepont, Pierig; Stickney, John T; Foster, Lauren A et al. (2008) Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity. Mutat Res 637:142-51
Bashour, Anne-Marie; Meng, J-J; Ip, Wallace et al. (2002) The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells. Mol Cell Biol 22:1150-7
Meng, J J; Ip, W (2001) A yeast two-hybrid approach for probing cytoskeletal protein interactions. Methods Mol Biol 161:255-68
Meng, J J; Lowrie, D J; Sun, H et al. (2000) Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin. J Neurosci Res 62:491-502